Protagonist Therapeutics PTGX Declines 319 Amid Market Weakness 20260517 LateNight Truth Social Posts A New Window Into Presidential Thinking and Market Sentiment New NPACW Stock Up 467 Key Resistance at 033 20260515 April Jobs Report Preview Modest Payroll Growth Expected as Labor Market Shows Signs of Cooling What Parke Bancorp PKBKs 109 Jump Means for Investors 20260520 General GPACU Holds 1009 Direction Awaited 20260521 Himax Technologies Surges 66 Amid Robust Semiconductor Demand OneMain Holdings OMF Q1 2026 Earnings Surprise EPS 195 Up Significant Trump Mobile Investigates Potential Data Exposure Affecting Thousands of Prospective Customers Soybean Futures Decline in Tuesday Trading Session Huawei Unveils New Chip Design Approach Plans Fall Smartphone Chip Launch Nomura Identifies Six Stocks Poised to Benefit from Indias Electric Vehicle Inflection Point Romantic Getaways in US Highlight Travel Industry Trends for 2026 Astral Carborundum Universal and NTPC in Focus This Week as Chart Patterns Suggest Potential Movement Polar Power Inc POLA Q1 2026 Earnings Net Loss of 005 Per Share Shares Fall 57 Amid Thin Disclosure Clear Secure Inc YOU Q1 2026 Earnings EPS Beats Estimates by 12 Despite Stock Pullback TMO Q1 2026 Earnings EPS Tops Estimates Amid Modest Stock Dip Canaan Inc Q1 2026 Earnings Deep EPS Miss Signals Continued Headwinds Theriva Biologics TOVX Q1 2026 Earnings Slight EPS Beat Boosts Sentiment for ClinicalStage Biotech Credit Suisses Neelkanth Mishra Sees Scope for Meaningful Rate Cuts Ahead Repo Rate May Hit Decade Low Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Lead Morning Squawk Retail Hiring Surge in April Contrasts with Cautious Consumer Signals SP Futures Rise as Treasury Yields Decline Investors Eye USIran Developments Milburn Welfare Spending on Youth Outpaces Job Investment Calls for Reform SpaceX OpenAI and Anthropic May Surpass Berkshire Hathaway on Market Debut Prediction Market Suggests Gold Prices in 2026 Analysts Weigh Potential Rally Amid Global Uncertainty PRLD Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Pipeline Advances